诺和诺德裁员背后:GLP-1赛道从“蓝海”杀入“红海

药事纵横
Sep 17

丹麦生物医药公司诺和诺德9月10日表示,公司将进行内部重组,并裁员9000人,以每年节省80亿丹麦克朗(约合12.6亿美元)的开支。裁员工作是新任首席执行官Maziar Mike Doustdar领导下的第一个重大举措。诺和诺德公司公布的声明中指出,要对公司进行全面改革,以简化组织架构、加快决策速度,并将资源重新分配至糖尿病和肥胖症领域的业务增长上。目前,该公司在全球拥有78400个工作岗位。对于...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10